172 related articles for article (PubMed ID: 3295020)
1. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
Morgan MY; Hawley KE; Stambuk D
J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020
[TBL] [Abstract][Full Text] [Related]
2. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
Morgan MY; Hawley KE
Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
[TBL] [Abstract][Full Text] [Related]
3. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
Morgan MY; Alonso M; Stanger LC
J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285
[TBL] [Abstract][Full Text] [Related]
4. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
[TBL] [Abstract][Full Text] [Related]
5. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
Lanthier PL; Morgan MY
Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
[TBL] [Abstract][Full Text] [Related]
6. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
Heredia D; Terés J; Orteu N; Rodés J
J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887
[TBL] [Abstract][Full Text] [Related]
7. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
[TBL] [Abstract][Full Text] [Related]
8. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt.
Riggio O; Balducci G; Ariosto F; Merli M; Pieche U; Pinto G; Tremiterra S; Ziparo V; Capocaccia L
Dig Dis Sci; 1989 Jun; 34(6):823-9. PubMed ID: 2656134
[TBL] [Abstract][Full Text] [Related]
9. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
Heredia D; Caballería J; Arroyo V; Ravelli G; Rodés J
J Hepatol; 1987 Jun; 4(3):293-8. PubMed ID: 3598162
[TBL] [Abstract][Full Text] [Related]
10. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
11. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients].
Grandi M; Sacchetti C; Pederzoli S; Celani MF
Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974
[TBL] [Abstract][Full Text] [Related]
12. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
[TBL] [Abstract][Full Text] [Related]
13. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
Blanc P; Daures JP; Rouillon JM; Peray P; Pierrugues R; Larrey D; Gremy F; Michel H
Hepatology; 1992 Feb; 15(2):222-8. PubMed ID: 1531204
[TBL] [Abstract][Full Text] [Related]
14. Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
Cammà C; Fiorello F; Tinè F; Marchesini G; Fabbri A; Pagliaro L
Dig Dis Sci; 1993 May; 38(5):916-22. PubMed ID: 8482191
[TBL] [Abstract][Full Text] [Related]
15. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study.
Pai CH; Huang YS; Jeng WC; Chan CY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):31-6. PubMed ID: 7712392
[TBL] [Abstract][Full Text] [Related]
16. Nonabsorbable disaccharides for hepatic encephalopathy.
Als-Nielsen B; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2004; (2):CD003044. PubMed ID: 15106187
[TBL] [Abstract][Full Text] [Related]
17. [1st use of lactitol in the treatment of porto-systemic encephalopathy].
Bircher J; Bührer M; Franz K; van Velthuijsen JA
Schweiz Med Wochenschr; 1982 Sep; 112(38):1306-7. PubMed ID: 7134954
[TBL] [Abstract][Full Text] [Related]
18. The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.
Merli M; Caschera M; Piat C; Pinto G; Diofebi M; Riggio O
J Clin Gastroenterol; 1992 Sep; 15(2):125-7. PubMed ID: 1401823
[TBL] [Abstract][Full Text] [Related]
19. Disaccharides in the treatment of hepatic encephalopathy.
Sharma P; Sharma BC
Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
[TBL] [Abstract][Full Text] [Related]
20. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
Morgan MY
Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
